Comparison of Human Embryonic Stem Cell-Derived Cardiomyocytes, Cardiovascular Progenitors, and Bone Marrow Mononuclear Cells for Cardiac Repair
Open Access
- 1 November 2015
- journal article
- research article
- Published by Elsevier in Stem Cell Reports
- Vol. 5 (5) , 753-762
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Experience from Experimental Cell Transplantation Therapy of Myocardial Infarction: What have we Learned?Cell Transplantation, 2013
- Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat heartsNature Biotechnology, 2007
- Human embryonic stem cell transplantation to repair the infarcted myocardiumHeart, 2007
- Cell transplantation to prevent heart failure: a comparison of cell typesThe Annals of Thoracic Surgery, 2003
- Comparison of Intracardiac Cell Transplantation: Autologous Skeletal Myoblasts Versus Bone Marrow CellsCirculation, 2003
- Beneficial effect of autologous cell transplantation on infarcted heart function: comparison between bone marrow stromal cells and heart cellsThe Annals of Thoracic Surgery, 2003
- Is Skeletal Myoblast Transplantation Clinically Relevant in the Era of Angiotensin-Converting Enzyme Inhibitors?Circulation, 2001
- Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac functionNature Medicine, 2001
- Stable labeled microspheres to measure perfusion: validation of a neutron activation assay techniqueAmerican Journal of Physiology-Heart and Circulatory Physiology, 2001
- Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular functionThe Journal of Thoracic and Cardiovascular Surgery, 2000